Table 4. Clinicopathological characteristics of NSCLC cases (n=39).

Clinicopathological variables	Patients (n=39), n (%)
ERβ expression in tumor tissue
High	32 (82.1)
Low	7 (17.9)
ERβ expression in normal adjacent tissue
High	9 (23.1)
Low	30 (76.9)
Gender
Male	23 (59.0)
Female	16 (41.0)
Histology
Adenocarcinoma	31 (79.5)
Squamous cell	8 (20.5)
Stage
IIIA	27 (69.2)
IIIB	12 (30.8)

NSCLC, non-small cell lung cancer; ERβ, estrogen receptor beta.